Despite significant progress in the past 20 years, graft-versus-host disease (GVHD) remains
a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell …

PURPOSE: To review recent advances in peripheral-blood progenitor-cell (PBPC)
transplantation in order to define the optimal cell dose required for autologous and …

Cancer is a major cause of death and the number of new cases, as well as the number of
individuals living with cancer, is expanding continuously. Due to the enormous propensity of …

Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity after
allogeneic bone marrow transplantation, but can be avoided by removing T lymphocytes …

This study analyzed the characteristics of 257 HLA-identical sibling transplants of
granulocyte colony-stimulating factor–mobilized peripheral blood progenitor cells depleted …

Acute graft-versus-host disease (AGVHD) severity is usually graded (grades 0–IV) by the
pattern of organ involvement using the classic Glucksberg–Seattle criteria (GSC). Recently …

Allogeneic transplantation: peripheral blood vs. bone marrow : Current Opinion in Oncology
Allogeneic transplantation: peripheral blood vs. bone marrow : Current Opinion in Oncology …

Unrelated donors are commonly used for hematopoietic stem cell transplants, but graft-
versus-host disease (GVHD) is a major problem. We investigated whether transplantation of …

Clinical results after T-cell–depleted allografts might be improved by modifying the graft
content of progenitor and accessory cells. Although the association of the number of donor T …

A study on 315 patients undergoing transplantation with CD34+ selected blood cells from
HLA-identical siblings was performed to determine risk factors for acute GVHD (aGVHD) …